Key stats
About China Universal Nasdaq Biotechnology Index Exchange Traded Fund Units
Home page
Inception date
Aug 15, 2022
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
China Universal Fund Management Co. Ltd.
ISIN
CNE100005C36
Tightly track the target index, and pursue the minimization of tracking deviation and tracking err.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks92.87%
Health Technology90.74%
Commercial Services1.17%
Technology Services0.51%
Health Services0.42%
Process Industries0.04%
Bonds, Cash & Other7.13%
Corporate6.22%
Cash0.91%
Stock breakdown by region
North America87.81%
Europe11.74%
Asia0.39%
Oceania0.07%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
513290 invests in stocks. The fund's major sectors are Health Technology, with 90.74% stocks, and Commercial Services, with 1.17% of the basket. The assets are mostly located in the North America region.
513290 top holdings are Gilead Sciences, Inc. and Amgen Inc., occupying 8.57% and 7.92% of the portfolio correspondingly.
No, 513290 doesn't pay dividends to its holders.
513290 shares are issued by China Universal Asset Management Co., Ltd. under the brand China Universal. The ETF was launched on Aug 15, 2022, and its management style is Passive.
513290 expense ratio is 0.65% meaning you'd have to pay 0.65% of your investment to help manage the fund.
513290 follows the NASDAQ Biotechnology Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
513290 invests in stocks.